InVision Precision Cardiac Amyloid
FDA 510(k) clearance K243866 · decided 2025-05-21
Clearance details
- K-number
- K243866
- Device name
- InVision Precision Cardiac Amyloid
- Applicant
- InVision Medical Technology Corporation
- Decision
- Substantially Equivalent
- Date received
- 2024-12-17
- Decision date
- 2025-05-21
- Days to decision
- 155 days
- Clearance type
- Traditional
- Product code
- SDJ
- Device class
- 2
- Regulation number
- 870.2200
- Medical specialty
- Cardiovascular
- Advisory committee
- Cardiovascular
- Location
- Los Angeles, CA, US
- Third-party review
- No
- Expedited review
- No
+ Add to Predicate Builder ◉ Watch InVision Medical Technology Corporation
Need this as data, not a web page?
Query all 176,000+ clearances through the Atlas FDA API, or subscribe to weekly change alerts. Self-serve from $29/mo.
Similar devices under this product code
Devices cleared under the same product code - the starting set for predicate research.
| Record | Firm | Date |
|---|---|---|
| Us2.ca (K250151) | Eko.Ai Pte Ltd. D/B/A Us2.Ai | 2025-06-20 |
| EchoGo Amyloidosis (1.0) (K240860) | Ultromics Limited | 2024-11-15 |
Recalls involving this device
No recalls on record reference this clearance.